Moderna’s (NASDAQ:MRNA) Q3 results confirmed on Thursday that the U.S. vaccine market for respiratory syncytial virus (RSV), ...

On Thursday, Moderna Inc (NASDAQ:MRNA) stock is trading higher after the company reported better-than-expected third-quarter ...

Moderna (MRNA) stock gains as company posts better than expected Q3 results driven by its updated COVID-19 vaccine. Read more ...

Moderna, Inc. (NASDAQ:MRNA) will release earnings results for its third quarter, before the opening bell on Thursday, Nov. 7.

Welcome to the Moderna third quarter 2024 conference call. [Operator instructions] Please be advised today's conference is ...

We recently published a list of the 10 Worst Performing Stocks in S&P 500 in 2024. In this article, we are going to take a ...

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we ...

Reports third quarter revenues of $1.9 billion, GAAP net income of $13 million and GAAP EPS of $0.03Achieves year-to-date product sales of $2.2 ...

US stocks extended gains on Thursday as investors continued to digest Donald Trump's electoral victory and awaited the Federal Reserve's policy decision due this afternoon. Meanwhile, the Dow Jones ...

Nasdaq made waves earlier this month as the company jumped into the upper echelon of risk and compliance organizations with a series of honors at the sector’s premier annual awards. Nasdaq jumped from ...

Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see ...

Below is Validea's guru fundamental report for MARRIOTT INTERNATIONAL INC (MAR). Of the 22 guru strategies we follow, MAR rates highest using our Multi-Factor Investor model based on the published ...